After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related cancer. New research presented at the European Congress on Obesity (ECO) in Malaga, Spain, and published in the journal…
Scientists Discover Powerful Anti-Cancer Benefits of Popular Weight Loss Drugs
